What Is KPV Peptide Used For?
What is KPV peptide used for? Explain this as adjacent research context, not a treatment HOD currently sells. Do not infer availability.
Reviewed by Taylor Anderson, RN
Aesthetic Registered Nurse
Taylor Anderson is an aesthetic registered nurse and a reviewer for Hot or Nothing.
Updated September 18, 2026
Quick answer
KPV is studied as an anti-inflammatory fragment of alpha-MSH for gut and skin inflammation, with less inflammatory signaling seen in lab cells and mouse colitis models. No human trial has shown it improves redness, gut-linked breakouts, or wound appearance.
In this guide
Key takeaways
- In dish and mouse work, KPV entered cells through PepT1 and lowered NF-kB and MAP kinase activity.
- The detailed wound result released KPV first and then a growth factor from a glucose-responsive film, not a tested cream or serum, and has not been tested in people.
- FDA listed wound healing and inflammatory conditions as nominated uses, and its May 2026 briefing said the nomination lacked adequate supporting information.
KPV is studied as an anti-inflammatory fragment of alpha-MSH for gut and skin inflammation, which is why it comes up for redness, gut-linked breakouts and slow repair, though human data remain limited (Empire clinician overview). In lab cells and mice it quieted inflammatory signals and eased colitis, and in diabetic mice a KPV-first dressing improved wound repair.
How is KPV thought to calm inflammation?
KPV stands for lysine, proline and valine, the last three building blocks of a natural immune-related molecule called alpha-melanocyte-stimulating hormone (Empire clinician overview). Researchers study this short piece because it keeps anti-inflammatory activity in lab models without the full effects of the parent molecule.
In human intestinal and immune cells grown in dishes, KPV entered cells through PepT1, a carrier that moves very small peptides inside, and lowered activity of NF-kB and MAP kinase, two internal switches that turn on inflammatory signals (Dalmasso study). Mice that received KPV in drinking water developed less bowel inflammation in two models of colitis and made fewer pro-inflammatory signals. A second mouse study reported similar anti-inflammatory activity in two colitis models (Kannengiesser 2008 report).
What has research shown for skin and wound repair?
Skin researchers picked up KPV because lingering inflammation can keep your skin looking red, uneven or slow to repair. No human trial has tested whether KPV changes that appearance.
The most detailed wound finding comes from diabetic mice with full-thickness skin wounds. Researchers applied a three-layer film that released KPV first to calm inflammation and then released epidermal growth factor, a protein that supports new tissue growth, and wounds closed faster with less inflammation, more new blood vessel growth and more collagen (2022 wound study). The study used a specialized glucose-responsive film. No cream or serum version was tested in that study, and researchers have not tested this approach in people.
What if you want better glow now?
KPV belongs with gut-skin inflammation research for now. Your skin looks brighter and more even when redness calms, texture smooths and tone looks consistent, and those changes respond more predictably to options with human skin data and a clear routine you can follow.
You can take the quiz to find a verified skin-glow plan matched to your concerns, with clinician review and pharmacy fulfillment through the HOD website. For regulatory context, the FDA listed wound healing and inflammatory conditions as the nominated uses when it reviewed KPV for the compounding bulk list in July 2026 (FDA meeting agenda). Its May 2026 briefing said the nomination lacked adequate supporting information and noted KPV was promoted in compounded regenerative combinations (FDA briefing document).
Ready to make a move?
Answer three questions to see the options, prices, and providers that fit your goals.
See My PlanFAQ
What is KPV made from?
KPV is lysine, proline and valine, the last three building blocks of alpha-melanocyte-stimulating hormone. Researchers study this short piece because it keeps anti-inflammatory activity in lab models without the full effects of the parent molecule.
Has KPV been tested in people for redness or glow?
No human trial has tested whether KPV changes redness, evenness, or repair appearance. Interest for skin comes from cell and mouse inflammation work and one diabetic-mouse wound study.
What did the main wound-healing experiment actually use?
Diabetic mice with full-thickness wounds received a three-layer glucose-responsive film that released KPV first and then epidermal growth factor. Wounds closed faster with less inflammation, more new blood vessel growth and more collagen. No cream or serum version was tested, and the approach has not been tested in people.
What uses did FDA list for KPV in its compounding review?
FDA listed wound healing and inflammatory conditions as the nominated uses when it reviewed KPV for the compounding bulk list in July 2026. Its May 2026 briefing said the nomination lacked adequate supporting information and noted KPV was promoted in compounded regenerative combinations.
Keep reading
Sources (20)
- KPV Anti-Inflammatory Research Summary | PeptideJournal · peptidejournal.org · captured September 18, 2026
- KPV Peptide: What It Is, Benefits, Dosing & Safety · empiremedicaltraining.com · captured September 18, 2026
- KPV Peptide Benefits: What the Research Actually Shows · peptidemind.com · captured September 18, 2026
- [PDF] Alpha-Melanocyte Stimulating Hormone: An Emerging Anti-Inflammatory Antimicrobial Peptide | Semantic Scholar · semanticscholar.org · captured September 18, 2026
- PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. · pubmed.ncbi.nlm.nih.gov · captured September 18, 2026
- KPV Tripeptide: Anti-Inflammatory Research, PCAC Vote Result & Molecular Data | Clinical Peptide · clinicalpeptide.org · captured September 18, 2026
- KPV for GI and Skin Inflammation: Clinical Research Summary · newtropin.com · captured September 18, 2026
- Melanocortin-derived tripeptide KPV has... : Inflammatory Bowel Diseases · ovid.com · captured September 18, 2026
- KPV: Anti-Inflammatory Alpha-MSH Fragment — Oral & IBD Data · peptpedia.org · captured September 18, 2026
- KPV Peptide for Wound Healing Research | KPV.com · kpv.com · captured September 18, 2026
- July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee - 07/23/2026 | FDA · fda.gov · captured September 18, 2026
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act · fda.gov · captured September 18, 2026
- 2026 Meeting Materials, Pharmacy Compounding Advisory Committee | FDA · fda.gov · captured September 18, 2026
- December 4, 2024 Pharmacy Compounding Advisory Committee (PCAC) Meeting · fda.gov · captured September 18, 2026
- FDA Briefing Document Pharmacy Compounding Advisory Committee (PCAC) Meeting July 23 - 24, 2026 · fda.gov · captured September 18, 2026
- Meeting of the Pharmacy Compounding Advisory Committee | FDA · fda.gov · captured September 18, 2026
- October 29, 2024 Pharmacy Compounding Advisory Committee (PCAC) Meeting · fda.gov · captured September 18, 2026
- July 23-24, 2026 Pharmacy Compounding Advisory Committee (PCAC) Meeting · fda.gov · captured September 18, 2026
- FDA Briefing Document Pharmacy Compounding Advisory Committee (PCAC) Meeting July 23 - 24, 2026 · fda.gov · captured September 18, 2026
- July 23-24, 2026 Pharmacy Compounding Advisory Committee (PCAC) Meeting · fda.gov · captured September 18, 2026
